Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd. (KYKOF) Revenue
Annual & quarterly revenue history · segment & region breakdown
KYKOF · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsKyowa Kirin Co., Ltd. trailing twelve-month (TTM) revenue is $512B, an increase of 0.34% year-over-year from $497B in FY2025.
Revenue trend
2025 – 2005 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $497B | +$1.70B | +0.34% |
| 2024-12-31 | $496B | +$53.33B | +12.06% |
| 2023-12-31 | $442B | +$43.86B | +11.01% |
| 2022-12-31 | $398B | +$46.13B | +13.09% |
| 2021-12-31 | $352B | +$33.89B | +10.65% |
| 2020-12-31 | $318B | +$12.53B | +4.10% |
| 2019-12-31 | $306B | -$40.71B | -11.75% |
| 2018-12-31 | $347B | -$6.85B | -1.94% |
| 2017-12-31 | $353B | +$10.36B | +3.02% |
| 2016-12-31 | $343B | -$21.30B | -5.85% |
Compare revenue vs peers
Drug Manufacturers - GeneralCompare KYKOF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Kyowa Kirin Co., Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Kyowa Kirin Co., Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in JPY.
Data sourced from Kyowa Kirin Co., Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
KYKOF revenue · 4 questionsKYKOF's trailing twelve-month (TTM) revenue is $512B. That is an increase of 0.34% year-over-year from $497B in FY2025.
▸ Source: FMP · Kyowa Kirin Co., Ltd. SEC filings · GAAP · Kyowa Kirin Co., Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026